Oppenheimer Updates Estimates of RLI Corp (RLI)

Symbols: RLI
Share

Oppenheimer reduced their estimates of RLI Corporation (NYSE: RLI) due to lower expected investment income and revised their 2010 and 2011 EPS estimates to $4.60 and $3.70, respectively.


 
 
< Previous
Piper Jaffray Reiterates Overweight Rating on Cephalon (CEPH)
Next >
FDA Issues Delay on Valeant Pharmaceuticals's Ezogabine (VRX)
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust